What is Cannalysis?
Founded in 2015 and headquartered in Santa Ana, California, Cannalysis operates as a licensed testing laboratory that bridges the gap between complex scientific analysis and consumer safety. By integrating proprietary technology with deep domain expertise, the firm provides a comprehensive suite of testing services essential for ensuring that cannabis and hemp products meet or exceed rigorous regulatory compliance standards. As the industry shifts toward professionalization, Cannalysis serves as a critical gatekeeper, providing the analytical data necessary for manufacturers to bring compliant, high-quality products to market. Their operational model is designed to scale alongside the broader industry, addressing the persistent need for standardized, reliable, and transparent testing protocols in a fragmented regulatory landscape.
How much funding has Cannalysis raised?
Cannalysis has raised a total of $23M across 2 funding rounds:
Angel/Seed
$1M
Series A
$22M
Angel/Seed (2017): $1M with participation from Casa Verde Capital
Series A (2019): $22M, investors not publicly disclosed
Key Investors in Cannalysis
Casa Verde Capital
Casa Verde is a premier venture capital firm dedicated exclusively to the cannabis industry, focusing on scalable and capital-efficient businesses that address long-term market needs.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Cannalysis?
With the successful closure of its latest financing round, Cannalysis is well-positioned to accelerate its operational footprint and enhance its technological capabilities. The company is expected to leverage this capital to expand its laboratory capacity and refine its proprietary testing methodologies, ensuring it remains at the forefront of the compliance-as-a-service model. As the cannabis sector continues to face evolving legislative hurdles, the demand for high-fidelity testing services is projected to rise, providing Cannalysis with a robust pipeline for long-term growth. Future strategic initiatives will likely focus on deepening market penetration in key states and potentially diversifying its service offerings to include advanced chemical analysis and supply chain verification tools, further cementing its role as an essential enterprise-level partner in the global cannabis ecosystem.
See full Cannalysis company page
